Dahej Pharma Factory Found Making Tramadol Illegally

Ahmedabad: In a well-planned operation, the Gujarat Anti-Terrorist Squad (ATS) on Tuesday confiscated 1,410 litres of illegal liquid tramadol — a precursor in the production of tramadol tablets — from a pharmaceutical establishment in Dahej. The street value of the seized stock has been estimated at Rs 31.02 crore.

Two prime suspects, Pankaj Rajput and Nikhil Kapuriya, have been arrested, leading to the unravelling of a complex multi-layered operation from manufacturing to distribution. The hunt for others in the network is on.

Tramadol, an opioid pain medication, was notified as a psychotropic substance under the NDPS Act in 2018 and its export is restricted.

The operation came after an ATS officer received intelligence indicating that Rajput, the chief chemist and operator of a pharmaceutical company, was clandestinely synthesizing tramadol at a pharmaceutical unit located on a plot within the Jolva GIDC in Dahej, Bharuch district.

Acting upon this information, ATS launched a covert investigation employing advanced technical surveillance and subsequently, the squad executed the raid in collaboration with the Special Operations Group.

Preliminary investigation and Rajput’s interrogation revealed that the confiscated liquid tramadol had been stocked by Rajput and Kapuriya to make tablets.

Kapuriya owns Maruti Biogenic, a bulk drug and chemical manufacturing and trading firm in Ankleshwar. Raw materials and chemical compounds needed in the production of tramadol active pharmaceutical ingredient (API) came from Harshad Kukadiya, who owns Shreeji Scientific in Sarkhej, Ahmedabad. After processing, Rajput and Kapuriya would transport the synthesized tramadol API back to Kukadiya through a man named Keval Gondaliya.

Next, Anand Patel and Ankit Patel, proprietors of Dnakor Pharma Pvt Ltd in Dhanot, Chhatral, manufactured and packaged the tablets under directives of the prime suspects Rajput and Kapuriya, besides Gondaliya and his aide Harshit Patel. Gondaliya and Patel also facilitated the tablets’ distribution.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit